However, there was no association of ZBTB16 methylation with clinicopathological characteristics of patients, including age, tumor grade and size, lymph node metastasis, distant metastasis, ER, PR, HER2, or p53 status. The gene discussed is TP53; the disease is metastatic malignant neoplasm in the lymph nodes.